申请人:Chai Tai Tianqing Pharmaceutical Group Co., Ltd.
公开号:EP3269715A1
公开(公告)日:2018-01-17
Disclosed is a substituted 2H-pyrazole derivative serving as a selective CDK4/6 inhibitor. Specifically, disclosed is a compound of formula (I) or a pharmaceutically acceptable salt thereof which serves as a selective CDK4/6 inhibitor.
公开了一种作为选择性 CDK4/6 抑制剂的取代 2H 吡唑衍生物。具体而言,公开了一种可作为选择性 CDK4/6 抑制剂的式 (I) 化合物或其药学上可接受的盐。